Expression of the Epstein-Barr virus gp350/220 gene in rodent and primate cells.

The gene encoding the Epstein-Barr virus envelope glycoproteins gp350 and gp220 was inserted downstream of the cytomegalovirus immediate-early, Moloney murine leukemia virus, mouse mammary tumor virus, or varicella-zoster virus gpI promoters in vectors containing selectable markers. Host cell and recombinant vector systems were defined which enabled the isolation of rodent or primate cell clones which expressed gp350/220 in substantial quantities. Continued expression of gp350/220 required maintenance of cells under positive selection for linked markers and periodic cloning. gp350/220 expressed in various host cells varied slightly in electrophoretic mobility, probably reflecting differences in glycosylation. Insertion of a stop codon into the gp350/220 open reading frame, upstream of the putative membrane anchor sequence, resulted in efficient secretion of truncated gp350 and gp220 from rat pituitary (GH3) cells. gp350/220 expressed in mammalian cells is highly immunogenic and elicits virus-neutralizing antibodies when administered to mice.     

Epstein-Barr病毒包膜糖蛋白gp85的原核表达

目的:利用大肠杆菌BL21诱导表达GST-gp85融合蛋白,进行动物免疫制备多克隆抗体。方法:通过PCR反应从EB病毒转染的绒猴淋巴细胞系B95-8细胞中获得了gp85BXLF2基因,将此基因克隆到大肠杆菌表达载体pGEX-5T,得到阳性克隆pGEX5T-85。转化大肠杆菌BL21,IPTG诱导表达重组蛋白,表达产物经SDS-PAGE分析、尿素变性、复性和亲和层析纯化,并用初步纯化的蛋白免疫BALB/c小鼠。结果:SDS-PAGE可见在相对分子质量约100000处有蛋白条带,Western印迹表明该蛋白可与免疫的BALB/c小鼠血清及鼻咽癌血清起特异性反应。结论:在大肠杆菌细胞中成功表达了GST-gp85融合蛋白,该蛋白具有较好的抗原性和免疫原性。     

Recombinant vaccinia virus induces neutralising antibodies in rabbits against Epstein-Barr virus membrane antigen gp340.

The Epstein-Barr virus membrane antigen gene gp340 was isolated, inserted into several strains of vaccinia virus and expressed under the control of a vaccinia virus promoter. The EBV-derived protein which was produced by the recombinant vaccinia viruses was heavily glycosylated, readily labelled with threonine, could be detected at the surface of infected cells and had a mol. wt. of approximately 340 kd, all of which are properties of the authentic gp340. Polyclonal rabbit antisera against gp340 and an EBV-neutralising anti-gp340 monoclonal antibody both recognised cells infected with the recombinant vaccinia viruses. Moreover, rabbits vaccinated with one of the recombinants produced antibodies that recognised EBV-containing lymphoblastoid cells and neutralised EBV.     

表达EB病毒主要膜蛋白gp350／220的非复制型重组痘苗病毒的构建

利用非复制痘苗病毒质粒载体pNEOCK11β75及pNEOCK,改造了表达EB病毒主要膜蛋白gp350/22的复制型重组痘苗病毒VMA,构建了非复制型重组痘苗病毒VMA△CK。该病毒能在鸡胚原代成纤维细胞（CEF）中正常繁殖,而在人源细胞中不能正常繁殖。在CEF中连续传代至第25代,经PCR证明,该病毒符合非复制型重组痘苗病毒的特征。经免疫荧光及免疫酶斑法证实,VMA△CK可稳定表达gp350/220,且表达水平与VAM无明显差异。VMA△CK经腹腔免疫Balb/C小鼠,4周后能诱生一定水平的抗gp350/220特异性抗体,加强免疫2周后该抗体水平明显升高。这一结果类似于VMA免疫Balb/C小鼠的结果,初免后,VMA△CK且抗痘苗抗体水平明显低于VMA免疫组;加强免疫2周后,两组小鼠的抗痘苗抗体水平趋于一致。上述结果证明,所构建的非复制痘苗病毒不影响目的抗原的表达,也不影响该抗原的免疫原性,但导致病毒毒力下降,而且用该病毒免疫小鼠后小鼠抗痘苗病毒载体的免疫反应明显下降。     

Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110.

The processing and intracellular localization of the two predominant Epstein-Barr virus glycoproteins expressed in late lytic infection were investigated. Immune light or electron microscopy of frozen fixed sections revealed that gp110 colocalized to the endoplasmic reticulum and to the nuclear membrane with the endoplasmic reticulum-resident protein, heavy-chain-binding protein (BiP), while gp350/220 accumulated in low abundance in the endoplasmic reticulum and was present in higher abundance in cytoplasmic structures presumed to be Golgi and in plasma membranes. Consistent with endoplasmic reticulum and nuclear membrane localization, the bulk of gp110 was sensitive to endoglycosidase H, indicating high-mannose, pre-Golgi, N-linked glycosylation; while consistent with Golgi and plasma membrane localization, gp350/220 was mostly resistant to endoglycosidase H because of complex N- and O-linked glycosylation. gp350/220 was as abundant in extracellular enveloped virus as in the plasma membrane but was much less abundant or undetected in internal cytoplasmic or nuclear membranes. In contrast, gp110-specific antibodies did not label extracellular or intracellular virus. These data indicate that the major antigenic components of gp110 are not incorporated into or are occluded in virions and that gp350/220 is added to virus in cytoplasmic transit through a process of de-envelopment and re-envelopment at the plasma membrane or at post-Golgi vesicles. Consistent with cytoplasmic de-envelopment and re-envelopment at the plasma membrane was the finding of some free nucleocapsids in the cytoplasm of cells with intact nuclear membranes and nucleocapsids which appeared to bud through the plasma membrane.     

Soluble gp350/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes.

The Epstein-Barr virus (EBV) major outer envelope glycoprotein complex, gp350/220, was known to be a ligand for CR2, a B-lymphocyte plasma membrane protein. By Scatchard analysis, soluble EBV gp350/220 binds with high affinity (KD, 1.2 x 10(-8) M) to approximately the same number of B-lymphocyte surface sites as do CR2-specific monoclonal antibodies. Soluble gp350, gp220, or an amino-terminal, 576-amino-acid gp220 derivative binds similarly to B-lymphocyte receptors. Soluble gp350/220, gp220, or even a 470-amino-acid, amino-terminal gp220 derivative blocks EBV adsorption or infection. These experiments demonstrate that (i) gp350/220 is the predominant or exclusive EBV ligand for B lymphocytes; (ii) ligand-receptor blockade can prevent lymphocyte infection by EBV; and (iii) the amino-terminal, 470-amino-acid domain of gp350/220 contains the key ligand domain(s). Consistent with the ligand domain(s) being in the amino-terminal half of gp220 are the findings that the gp350/220-specific, EBV-neutralizing monoclonal antibody 72A1 blocks EBV adsorption by recognizing an epitope in the amino-terminal 470 (probably within the amino-terminal 162) amino acids and a deletion of amino-terminal amino acids 28 and 29 from gp350/220 inactivates ligand activity.     

HIV包膜蛋白Gp120在果蝇Schneider 2细胞内的表达纯化及初步性质鉴定

构建pMT/BiP/V5-HisA-HIVgp120真核表达载体,通过稳定转染获得稳定表达gp120蛋白的果蝇Schnei-der2(S2)细胞系,并对gp120蛋白进行大量表达和纯化。应用聚合酶链式反应技术从重组载体PVR1012-gp120中扩增出中国流行株CRF07-BCgp120全长基因后,将其插入载体pMT/BiP/V5-HisA。应用脂质体转染技术将真核表达载体和抗性筛选质粒共转染果蝇S2细胞,通过杀稻瘟菌素反复筛选,建立稳定高表达gp120蛋白的果蝇S2细胞系,并通过镍柱亲和层析和分子筛法纯化目的蛋白。用SDS-PAGE对重组蛋白的分子量和纯度进行分析,并通过Western blot和酶联免疫吸附技术(ELISA)对其进行鉴定。成功构建了gp120真核表达载体并获得了稳定转染该蛋白的果蝇S2细胞系,成功的表达了具有良好抗体反应性的gp120全长蛋白。此结果为深入研究HIV包膜蛋白gp120的生物学特性及进行HIV疫苗的研究提供了良好的物质基础。     

Effect of tandem rare codon substitution and vector-host combinations on the expression of the EBV gp110 C-terminal domain in Escherichia coli

Gp110 of Epstein-Barr virus (EBV) is a glycoprotein that functions exclusively during the assembly of EBV nucleocapsid and the release of infectious EBV. Its C-terminal tail domain (gp110 CTD) is essential for gp110's function and may provide signals that are responsible for the assembly and release of EBV. In the present study, to get large amounts of gp110 CTD for structural analysis, the effects of vector system, codon usage, and host strain on expression levels of gp110 CTD in Escherichia coli have been investigated. The coding region of gp110 CTD (11 kDa) was subcloned into the expression vectors pSE 280, pET-15b, pET-29a, pMAL-c2x, and pGEX-4T-1. Except the pMAL-c2x construct, all the others failed to express detectable amounts of recombinant gp110 CTD. Substituting a tandem rare AGA (Arg) codon with a synonymous CGC (Arg) codon facilitated expression of the recombinant protein, while a protease-deficient host E. coli strain helped in the accumulation of a soluble form of gp110 CTD fusion. The secondary structures of the obtained recombinant gp110 CTD purified from soluble extracts and inclusion bodies were compared using circular dichroism analysis. In aqueous solutions, both samples equally adopt a mixed alpha-helix and beta-sheet conformation as well as a partly unordered structure. Notably, in the membrane-mimicking environments the helical propensity of gp110 CTD increased up to the previously predicted level based on its sequence, suggesting that gp110 CTD may fold into a more stable conformation through interactions with the cell membrane.     

小鼠白细胞介素33真核表达质粒的构建及表达

克隆小鼠IL-33基因构建其真核表达质粒,并转染COS-7细胞检测其表达。提取C57BL/6小鼠肺组织总RNA,经反转录聚合酶链式反应（RT-PCR）扩增小鼠IL-33基因,酶切后插入pcDNA^TM3.1/myc HisA构建其真核表达质粒pcDNA-3.1-IL-33,重组质粒转染COS-7细胞,RT-PCR和免疫印迹法（western blotting）检测目的基因表达。结果显示,pcDNA3.1-IL-33中插入的片段序列测定结果与小鼠IL-33cDNA序列一致,重组质粒转染COS-7细胞后检测到相应mRNA及蛋白表达。成功克隆了小鼠IL-33基因cDNA,并构建其真核表达质粒。     

HIV-1B亚型gp120基因密码子优化前后免疫原性的比较

对HIV-1B亚型gp120基因按照哺乳动物优势密码子的使用原则进行优化,以Westem blot方法比较其体外表达量.将优化前的野生型gp120基因和改造后的modgp120基因插入重组腺伴随病毒载体,构建了重组病毒rAAV-wtgp120和rAAV-modgp120,比较两者免疫Balb/C小鼠后的抗体和CTL应答.Western blot检测结果显示:优化后基因的体外表达量明显高于野生型基因,rAAV-modgp120与rAAV-wtgp120相比可更好地诱导Balb/C小鼠的CTL应答,但检测不到明显的抗体反应.由此得出结论,优化后gp120基因的体外表达量明显高于野生型基因,并且可以诱导更强的特异性CTL应答,但检测不到gp120抗体.     

康乃馨ACC氧化酶cDNA的克隆及其反义植物表达载体的构建

以康乃馨（Dianthus caryophyllus L.)花瓣为材料,用改进的异硫氰酸胍一步法提取总RNA,根据已报道的康乃馨ACC氧化酶（1-aminocyclopropane-1-carboxylic acid oxidase,CO)基因的序列设计产合成一对引物,通过RT-PCR方法获得一约1.2kb特异片段,把该片段连接pGEM^(R)-Teasy vector上进行测序,其全长共1156bp,编码区915bp。共编码304个氨基酸残基,序列分析结果表明该序列与GenBankL35152中的康乃馨ACC氧化酶基因的cDNA序列完全相符,推断该基因在康乃馨种内可能是完全或高度保守的,随 后将此片段反向插入植物表达载体pBI121的35S启动子和NOS终止子之间,构建了一反义植物表达载体pBO;又把花特异表达启动子PchsA插入pBI121的HindⅢ Xbal位点构建中间载体pGHB,再把康乃馨ACC氧化酶基因反向插入中间载体pCHB的XbaI Satl位点构建成另一反义植物表达载体pCBO。     

CLONING OF MELITTIN cDNA FROM HONEYBEE INTO THE HIGH EXPREHION PLASMID OF ESCHERICHIA COLI*

Abstract Total mRNA from venom glands of newly emerged queen bees was reversely transcribed into cDNA and cloned into the EcoRI site of plasmid λgt11; cDNA library for bee venom was thus constructed. PCR technique was used to produce the melittin coding sequence from the cDNA library. A 87 bp product was produced and inserted into the EcoRI and PstI sites of the high level expression vector pBV220. Recombinant plasmid pBM95 was transformed into the competent cells of E.coli JM101. After screening transformants on LB medium with ampicilin, structure of the recombinant plasmid pBM95 from transformants was analyzed and melittin gene in pBM95 was sequenced. The cloned cDNA coding for honey bee melittin was obtained.     

A bacterial cell that synthesizes a protein containing the antigenic determinants of rat prolactin.

Bacterial minicells containing three different recombinant plasmids with rat prolactin cDNA sequences inserted at the Pst I site of pBR322 via the poly(dG):poly(dC) joining technique were examined for the expression of rat prolactin antigenic determinants. The three prolactin coding sequences were in the same orientation as the coding sequence of the ampicillin-resistance gene of pBR322. The presence of each of the three recombinant plasmids induced some prolactin synthesis by the bacteria as measured by immunoprecipitation with anti-prolactin antisera. About 10% of the protein synthesized from one of the plasmids, prl 3, precipitated with the antisera. These prolactin antigenic determinants were part of a larger fused protein.     

甘丙肽重构基因GAL（intronⅡ）的克隆及其过表达转基因载体的构建

目的克隆甘丙肽重构基因GAL（intronⅡ）,构建小鼠神经系统特异性表达甘丙肽（galanin,GAL）的转基因载体pUC18/PDGF-β-promoter/GAL（intronⅡ）,为制备GAL转基因小鼠做准备。方法通过常规PCR、RT-PCR及重叠延伸PCR（overlap extension PCR,OE-PCR）扩增出插入GAL第二内含子的GAL全长cDNA的重构基因GAL（intronⅡ）,将GAL（intronⅡ）克隆入T载体进行酶切、测序鉴定;同时从psisCAT6α中切下血小板源性生长因子β链（platelet-derived growth factor beta polypeptide,PDGF-β）启动子片段连接到空载体pUC18上构建出重组载体pUC18/PDGF-β-promoter;然后将GAL（intronⅡ）定向克隆于pUC18/PDGF-β-promoter下游,构建转基因载体pUC18/PDGF-β-promoter/GAL（intronⅡ）。结果 PCR和限制性内切酶分析鉴定,表明获得转基因载体pUC18/PDGF-β-promoter/GAL（intronⅡ）。通过对重构基因GAL（intronⅡ）的GALcDNA和第二内含子序列测序证实其与GenBank中的标准序列一致,GAL（intronⅡ）中第二内含子插入的位置准确,且无移码。结论使用重叠延伸PCR扩增重构基因GAL（intronⅡ）并成功构建转基因载体pUC18/PDGF-β-promoter/GAL（intronⅡ）,为转基因小鼠制备奠定一定的实验基础。     

An Epstein-Barr virus DNA fragment encodes messages for the two major envelope glycoproteins (gp350/300 and gp220/200).

The genes encoding the two major Epstein-Barr virus glycoproteins (gp350/300 and gp220/200) have been mapped to a 5-kilobase fragment of the viral genome (BamHI-L). This fragment encodes 3.4- and 2.8-kilobase RNAs which translate proteins of 135 and 100 kilodaltons, respectively. Both proteins react with antiserum specific for gp350/300 and gp220/200. The 135-kilodalton protein is identical in size to the nascent polypeptide precursor to gp350/300, and the 100-kilodalton protein is the expected size of the polypeptide precursor to gp220/200.     

J亚群禽白血病病毒跨膜蛋白gp37基因克隆与表达

禽白血病病毒(ALV)跨膜蛋白(TM)在病毒-细胞融合过程中起关键作用,其蛋白内部存在的许多高度保守序列有可能成为抗病毒的重要靶点。对TM结构和功能的深入研究将为抗禽白血病病毒乃至其它反转录病毒相关制剂的研制提供科学的理论基础。本研究通过PCR从本实验室分离的ALV-J山东汶上毒株获得表达TM的gp37基因,克隆连接pMD18-T载体并测序,从已构建的质粒pMD18-T-gp37中酶切回收gp37基因,构建重组转移载体pFastBacHTb-gp37。利用昆虫杆状病毒表达系统对gp37基因进行表达,通过间接免疫荧光和Western blot检测gp37基因表达产物,间接免疫荧光显示,重组杆状病毒感染的sf9细胞呈现明显的强阳性反应;Western blot分析,重组病毒感染的sf9细胞蛋白显示出约21kD的阳性条带。结果表明,gp37基因在sf9细胞内表达成功。     

Intron-dependent accumulation of mRNA in Coriolus hirsutus of lignin peroxidase gene the product of which is involved in conversion/degradation of polychlorinated aromatic hydrocarbons

The homobasidiomycete Coriolus hirsutus coding sequences of a lignin peroxidase (LiP) gene (lip, containing six (I-VI) introns), a lip cDNA (lipc), and three lipc derivatives containing one (I), three (I-III), or five (I-V) introns were inserted into chromosome-integrating expression vector. These recombinant plasmids were introduced into C. hirustus monokaryotic strain. The transformant carrying the promoter-lipc-terminator cassette did not contain enough mRNA molecules to be detectable by Northern-blot analysis. On the other hand, all the transformants carrying cassettes of genomic lip and intron(s)-containing lipc sequences contained sufficient amounts of mRNAs to be easily detected by Northern-blot analysis. LiP activities in the culture supernatants of these transformants were found to be about five times as high as those of transformants carrying the lipc cassette (or no cassette). The culture supernatants of the transformants with high LiP activity showed remarkably high conversion activity toward pentachlorophenol (PCP) and degradation activity toward 2,7-dichlorodibenzo-p-dioxin (2,7-DCDD). These results indicate that at least one intron (intron I) is required for accumulation of lip mRNA and its subsequent translational expression in C. hirsutus.